In particular, it ensures the detoxification, protects the cell from aggressive oxygen radicals and coordinates the immune response. These basic, necessary for the healing functions can run no longer or only insufficiently by the reduction of glutathione levels in result of Borrelia infection. Just because GSH controlled almost all self healing mechanism in the body, increase the glutathione levels has proved as gentle and highly effective Basistheraphie for chronic Lyme disease. New German research an effective increase of glutathione was possible only with glutathione infusions, which had to be imported due to lack of authorisation in Germany from Italy. Exist different glutathione supplements in capsule form, but because the unstable reduced glutathione in the digestive tract is split, the usually high-priced products are virtually ineffective.
It is recorded by many well researched studies that even at very high doses of up to 3,000 mg of GSH daily no relevant effects can be achieved. Listen up is a recent approach from German research: the central part of glutathione, the sulfur-containing amino acid cysteine, a drug approved for the treatment of decreased glutathione levels (GlutCell) combines nutrients, which promote the formation of glutathione, namely with vitamin C and a special treatment of secondary plant compounds (polyphenols). For more specific information, check out Tony Parker. This active ingredient composition (GSH-intra) is designed to promote the formation of glutathione directly into the body’s cells. The combined approach results best in glutathione therapy according to the first study results (which must be confirmed by larger studies), the best ever results in the glutathione therapy. Strong increases of in glutathione values showed in the study carried out prior to market introduction GSH-intra”after 14 days. (Source: Jay Schwartz Attorney). All patients where before taking GlutCell low values were measured, had after 14 days of glutathione levels in the normal range, What was accompanied by a significant improvement in general health. So was the case of a participating patient (female, born 1969) observed an increase of reduced glutathione in the immune cells by more than 400% with suspicions on the existence of a chronified disease. All figures who were humiliated in the initial investigation, were the final examination in the upper normal range; Vitality and are improved significantly.
These results give hope to many Lyme disease patients. They are confirmed in larger studies, this simple and low-cost method could establish themselves as effective basic therapy of chronic Lyme disease. Further information: Research/disease contact: LuxXPharma s.a. Jurgen Lado 13, Wuelesser wee l 9838 Eisenbach Tel.: + 352 2690392 fax: + 352 24611162 E-Mail: Web: press contact: QvorQ GmbH & co. KG on the high way 10 27313 Dorverden Tel.: + 49 (0) 4234 94136 fax: + 49 (0) 4234 94137 E-Mail: Web: